diethyl vinyl phosphonate | 7727-44-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机膦酸及其衍生物
• 英文名称: diethyl vinyl phosphonate
• 英文别名: Ethylphosphonsaeure-ethylester-vinylester；1-[Ethenoxy(ethyl)phosphoryl]oxyethane
• CAS: 7727-44-8
• 化学式: C₆H₁₃O₃P
• 分子量: 164.141
• InChiKey: NKEJLFPCGNPKFK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  10
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  diethyl vinyl phosphonate 在 ammonium hydroxide 作用下， 以 水 为溶剂， 生成 diethyl (2-aminoethyl)phosphonate
  参考文献：
  名称：

  H2dpa derivatives containing pentadentate ligands: An acyclic adjuvant potentiates meropenem activity in vitro and in vivo against metallo-β-lactamase-producing Enterobacterales

  摘要：

  DOI：

  10.1016/j.ejmech.2021.113702
• 作为产物：
  描述：

  O,O-Diethyl o-vinyl phosphite 在 碘乙烷 作用下， 生成 diethyl vinyl phosphonate
  参考文献：
  名称：

  Lutsenko,I.F.; Kraits,Z.S., Doklady Chemistry, 1960, vol. 132, p. 577 - 579

  摘要：

  DOI：

文献信息

• Site-selective carbon–carbon bond formation in unprotected monosaccharides using photoredox catalysis
  作者：Ieng Chim (Steven) Wan、Martin D. Witte、Adriaan J. Minnaard

  DOI：10.1039/c7cc01416c

  日期：——

  with somophiles readily enable branching of the carbon skeleton of unprotected glucosides, allosides, and xylosides regioselectively at C3. These reactions open the possibility of selective C–C bond formation in monosaccharides without multi-step protection–deprotection strategies.

  与嗜睡菌的定点选择性光氧化还原反应可以使C3区域选择性地保护未保护的糖苷，同素异物和木糖苷的碳骨架。这些反应打开了单糖中选择性C–C键形成的可能性，而无需采取多步保护-去保护策略。
• [EN] ISOXAZOLINE DERIVATIVES AND THEIR USE AS HERBICIDES<br/>[FR] DÉRIVÉS D'ISOXAZOLINE ET LEUR UTILISATION COMME HERBICIDES
  申请人：SYNGENTA LTD

  公开号：WO2006024820A1

  公开（公告）日：2006-03-09

  Compounds of formula (I) wherein the substituents are as defined in claim 1, are suitable for use as herbicides. Also claimed is a process for the preparation of compounds of the formula I, wherein m is 2 and n is 1, and the other substituents are defined as in claim 1, formula (Ia) by reacting a compound of the formula Ia in a single step or stepwise in succession with compounds of the formula R5-X and/or R6-X, wherein R5 and R6 are as defined in claim 1, and X is a leaving group, and a process for the preparation of compounds of the formula I, wherein R6 is C1­-C10alkyl or halogen, m is 2 and n is 1, and the other substituents are defined as in claim 1, formula (Ib) by reacting a compound of the formula 1b with a compound of the formula R5-X, wherein R5 is as defined in claim 1, and X is a leaving group, and a process for the preparation of compounds of the formula I, wherein R5 is chlorine, bromine or iodine, m is 1 or 2, and n is 1, and the other substituents are defined as in claim 1, formula (Ic) by reacting a compound of the formula le with an N- halosuccinimide and an oxidising agent.

  式(I)中的化合物，其中取代基如权利要求1所定义，适用作为除草剂。还声明了一种制备式I的化合物的方法，其中m为2，n为1，其他取代基如权利要求1所定义，通过将式Ia的化合物与式R5-X和/或R6-X的化合物在单步或连续逐步反应，其中R5和R6如权利要求1所定义，X为脱离基，制备式(Ia)的方法，并声明了一种制备式I的化合物的方法，其中R6为C1-C10烷基或卤素，m为2，n为1，其他取代基如权利要求1所定义，通过将式1b的化合物与式R5-X的化合物反应，其中R5如权利要求1所定义，X为脱离基，制备式(Ib)的方法，并声明了一种制备式I的化合物的方法，其中R5为氯、溴或碘，m为1或2，n为1，其他取代基如权利要求1所定义，通过将式le的化合物与N-卤代琥珀酰亚胺和氧化剂反应，制备式(Ic)的方法。
• Heterocyclic Compounds
  申请人：Yen Chi-Feng

  公开号：US20090264339A1

  公开（公告）日：2009-10-22

  This invention relates to heterocyclic compounds of the formulas shown in the specification. It also relates to methods for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, and tissue injuries with one of the heterocyclic compounds.

  这项发明涉及规范中所示的异环化合物。它还涉及使用其中一种异环化合物治疗炎症性疾病或免疫性疾病、发育性或退行性疾病以及组织损伤的方法。
• [EN] LIGAND-CONTROLLED C(SP3)-H ARYLATION AND OLEFINATION IN SYNTHESIS OF UNNATURAL CHIRAL ALPHA AMINO ACIDS<br/>[FR] ARYLATION COMMANDÉE PAR LIGAND DE C(SP3)-H ET OLÉFINATION UTILISABLES DANS LE CADRE DE LA SYNTHÈSE D'ACIDES ALPHA-AMINÉS CHIRAUX NON NATURELS
  申请人：SCRIPPS RESEARCH INST

  公开号：WO2015131100A1

  公开（公告）日：2015-09-03

  The use of ligands to tune the reactivity and selectivity of transition metal-catalysts for C(-sp3)-H bond functionalization is a central challenge in synthetic organic chemistry. Herein, we report a rare example of catalyst-controlled C(sp3)-H arylation using pyridine and quinoline derivatives: the former promotes exclusive monoarylation, whereas the latter activates the catalyst further to achieve diarylation. Successive application of these ligands enables the sequential diarylation of a methyl group in an alanine derivative with two different aryl iodides, affording a wide range of β-Ar-p-Ar ' -cc-amino acids with excellent levels of diastereoselectivity (d.r. > 20:1). Both configurations of the β-chiral center can be accessed by choosing the order in which the aryl groups are installed. The use of a quinoline derivative as a ligand also enables C(sp3)-H olefination of a protected alanine.

  使用配体调节过渡金属催化剂对C(-sp3)-H键官能化的反应性和选择性是合成有机化学中的一个核心挑战。在这里，我们报告了一个罕见的催化剂控制的C(sp3)-H芳基化的例子，使用吡啶和喹啉衍生物：前者促进了独特的单芳基化，而后者进一步激活了催化剂以实现二芳基化。这些配体的连续应用使得在丙氨酸衍生物中的甲基基团上进行顺序二芳基化成为可能，使用两种不同的芳基碘化物，得到了一系列具有优异立体选择性的β-Ar-p-Ar' -cc-氨基酸（d.r. > 20:1）。通过选择芳基基团的安装顺序，可以访问β-手性中心的两种构型。使用喹啉衍生物作为配体还可以实现保护丙氨酸的C(sp3)-H烯烃化。
• ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY, AND MODULE
  申请人：DAIKIN INDUSTRIES, LTD.

  公开号：US20200280096A1

  公开（公告）日：2020-09-03

  An electrolyte solution containing a compound represented by the following formula (1): wherein R 101 and R 102 are the same as or different from each other and are each a hydrogen atom, a fluorine atom, or an alkyl group optionally containing a fluorine atom; and R 103 is an alkyl group or an organic group containing an unsaturated carbon-carbon bond. Also disclosed is an electrochemical device and lithium ion secondary battery including the electrolyte solution, and a module including the electrochemical device or lithium ion secondary battery.

  一种电解质溶液，包含由以下化学式（1）表示的化合物：其中R101和R102彼此相同或不同，分别为氢原子、氟原子或含有氟原子的烷基基团；R103为烷基基团或含有不饱和碳-碳键的有机基团。还公开了包括该电解质溶液的电化学器件和锂离子二次电池，以及包括电化学器件或锂离子二次电池的模块。